KR930010496B1 - 폴리-4-아미노피롤-2-카복스아미도 유도체의 제조방법 - Google Patents

폴리-4-아미노피롤-2-카복스아미도 유도체의 제조방법 Download PDF

Info

Publication number
KR930010496B1
KR930010496B1 KR1019860005715A KR860005715A KR930010496B1 KR 930010496 B1 KR930010496 B1 KR 930010496B1 KR 1019860005715 A KR1019860005715 A KR 1019860005715A KR 860005715 A KR860005715 A KR 860005715A KR 930010496 B1 KR930010496 B1 KR 930010496B1
Authority
KR
South Korea
Prior art keywords
methyl
carboxamido
pyrrole
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019860005715A
Other languages
English (en)
Korean (ko)
Other versions
KR870001201A (ko
Inventor
아르카모네 페데리코
몬겔리 니콜라
펜코 세르지오
Original Assignee
팜이탈리아 카를로 엘바 에스.피.에이.
비토리노 페라리오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858517922A external-priority patent/GB8517922D0/en
Priority claimed from GB868613594A external-priority patent/GB8613594D0/en
Application filed by 팜이탈리아 카를로 엘바 에스.피.에이., 비토리노 페라리오 filed Critical 팜이탈리아 카를로 엘바 에스.피.에이.
Publication of KR870001201A publication Critical patent/KR870001201A/ko
Application granted granted Critical
Publication of KR930010496B1 publication Critical patent/KR930010496B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1019860005715A 1985-07-16 1986-07-15 폴리-4-아미노피롤-2-카복스아미도 유도체의 제조방법 Expired - Fee Related KR930010496B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858517922A GB8517922D0 (en) 1985-07-16 1985-07-16 Carboxamido derivatives
GB8517922 1985-07-16
GB868613594A GB8613594D0 (en) 1986-06-04 1986-06-04 Poly-4-aminopyrrole-2-carboxamido derivatives
GB8613594 1986-06-04

Publications (2)

Publication Number Publication Date
KR870001201A KR870001201A (ko) 1987-03-12
KR930010496B1 true KR930010496B1 (ko) 1993-10-25

Family

ID=26289538

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860005715A Expired - Fee Related KR930010496B1 (ko) 1985-07-16 1986-07-15 폴리-4-아미노피롤-2-카복스아미도 유도체의 제조방법

Country Status (26)

Country Link
JP (1) JPH0780843B2 (enrdf_load_stackoverflow)
KR (1) KR930010496B1 (enrdf_load_stackoverflow)
CN (1) CN1018825B (enrdf_load_stackoverflow)
AT (1) AT387013B (enrdf_load_stackoverflow)
AU (1) AU587841B2 (enrdf_load_stackoverflow)
BE (1) BE905110A (enrdf_load_stackoverflow)
CA (1) CA1285934C (enrdf_load_stackoverflow)
CH (1) CH674206A5 (enrdf_load_stackoverflow)
CS (1) CS276981B6 (enrdf_load_stackoverflow)
DE (1) DE3623880A1 (enrdf_load_stackoverflow)
DK (1) DK335986A (enrdf_load_stackoverflow)
ES (1) ES2000502A6 (enrdf_load_stackoverflow)
FI (1) FI83640C (enrdf_load_stackoverflow)
FR (1) FR2585018B1 (enrdf_load_stackoverflow)
GB (1) GB2178036B (enrdf_load_stackoverflow)
GR (1) GR861841B (enrdf_load_stackoverflow)
HU (1) HU205949B (enrdf_load_stackoverflow)
IE (1) IE59073B1 (enrdf_load_stackoverflow)
IL (1) IL79402A (enrdf_load_stackoverflow)
IT (1) IT1196488B (enrdf_load_stackoverflow)
NL (1) NL8601837A (enrdf_load_stackoverflow)
NO (1) NO168826C (enrdf_load_stackoverflow)
NZ (1) NZ216829A (enrdf_load_stackoverflow)
PH (1) PH24714A (enrdf_load_stackoverflow)
PT (1) PT82984B (enrdf_load_stackoverflow)
SE (1) SE468642B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
IT1243389B (it) * 1990-11-22 1994-06-10 Menarini Farma Ind Derivati poliaminopirrolcarbossiamidici, processi di preparazione e composizioni farmaceutiche che li contengono.
CA2103665C (en) * 1991-02-06 2003-04-15 J. William Lown Oligopeptide antiretroviral agents
IT1247878B (it) * 1991-02-15 1995-01-05 Menarini Farma Ind Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
GB2260134A (en) * 1991-10-04 1993-04-07 Erba Carlo Spa Derivatives of poly-5-amino-3-carboxy-1-methyl compounds
IT1262921B (it) * 1992-01-10 1996-07-22 Federico Arcamone Agenti antitumorali analoghi di oligopeptidi pirrol-amidinici retroversi processi di preparazione e prodotti farmaceutici che li contengono
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5717110A (en) * 1995-09-12 1998-02-10 Kyowa Hakko Kogyo Co., Ltd. UCH15 compounds
EP0880499A1 (en) * 1996-02-02 1998-12-02 PHARMACIA & UPJOHN S.p.A. Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR86210E (enrdf_load_stackoverflow) * 1963-04-04 1966-03-23
BR6461040D0 (pt) * 1963-07-26 1973-08-02 Farmaceutici Italia Processo para preparar novos derivados de pirrol
DE1795539A1 (de) * 1963-07-26 1972-01-13 Farmaceutici Italia Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
BE666612A (enrdf_load_stackoverflow) * 1963-07-26 1965-11-03
NL130086C (enrdf_load_stackoverflow) * 1964-07-14 1970-06-15
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法

Also Published As

Publication number Publication date
HUT43088A (en) 1987-09-28
FR2585018A1 (fr) 1987-01-23
SE8603098D0 (sv) 1986-07-11
GR861841B (en) 1986-11-18
NO168826C (no) 1992-04-08
NO168826B (no) 1991-12-30
SE8603098L (sv) 1987-01-17
FI83640C (fi) 1991-08-12
GB8617292D0 (en) 1986-08-20
KR870001201A (ko) 1987-03-12
JPH0780843B2 (ja) 1995-08-30
PT82984B (pt) 1989-01-30
BE905110A (fr) 1987-01-15
FI83640B (fi) 1991-04-30
DK335986D0 (da) 1986-07-15
CN86104787A (zh) 1987-02-18
SE468642B (sv) 1993-02-22
DE3623880A1 (de) 1987-01-29
DK335986A (da) 1987-01-17
AU587841B2 (en) 1989-08-31
ES2000502A6 (es) 1988-03-01
IE861875L (en) 1987-01-16
CS8605412A2 (en) 1991-03-12
GB2178036B (en) 1989-08-16
PH24714A (en) 1990-10-01
NZ216829A (en) 1989-03-29
ATA188886A (de) 1988-04-15
NO862860D0 (no) 1986-07-15
FI862959A0 (fi) 1986-07-16
IT1196488B (it) 1988-11-16
HU205949B (en) 1992-07-28
AT387013B (de) 1988-11-25
CH674206A5 (enrdf_load_stackoverflow) 1990-05-15
NO862860L (no) 1987-01-19
GB2178036A (en) 1987-02-04
IT8621125A1 (it) 1988-01-15
JPS6277362A (ja) 1987-04-09
FI862959A7 (fi) 1987-01-17
CN1018825B (zh) 1992-10-28
IL79402A0 (en) 1986-10-31
CA1285934C (en) 1991-07-09
NL8601837A (nl) 1987-02-16
IT8621125A0 (it) 1986-07-15
FR2585018B1 (fr) 1989-07-13
CS276981B6 (en) 1992-11-18
PT82984A (en) 1986-08-01
IL79402A (en) 1991-06-10
IE59073B1 (en) 1994-01-12
AU6020286A (en) 1987-01-22

Similar Documents

Publication Publication Date Title
KR930010496B1 (ko) 폴리-4-아미노피롤-2-카복스아미도 유도체의 제조방법
EP0246868B1 (en) Site specific alkylating agents
FI90422C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten purinyyli- ja pyrimidinyylisyklobutaanijohdannaisten valmistamiseksi
AU635733B2 (en) Acryloyl substituted pyrrole derivatives
KR940003495B1 (ko) 디스타마이신 a유도체의 제조방법
US5049579A (en) Site specific alkylating agents
US5310752A (en) Site specific alkylating agents
EP0424899A2 (en) Novel anthracycline glycoside derivatives and preparing method thereof
US5126347A (en) Isomeric dideoxynuclesides
KR20000010992A (ko) 디스타마이신 유도체, 이의 제조 방법, 및 항암 및 항바이러스제제로서의 이들의 용도
HK1006456B (en) Acryloyl substituted pyrrole derivatives
HU196590B (en) Process for producing benzoyl ester derivatives and pharmaceutics comprising them as active ingredient

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 19971016

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19981026

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19981026

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000